基于 AAV 的 CRISPR-Cas9 基因组编辑:挑战与工程机遇

IF 4.7 3区 工程技术 Q2 ENGINEERING, BIOMEDICAL Current Opinion in Biomedical Engineering Pub Date : 2023-12-07 DOI:10.1016/j.cobme.2023.100517
Ami M. Kabadi , Maria Katherine Mejia-Guerra , John D. Graef , Sohrab Z. Khan , Eric M. Walton , Xinzhu Wang , Charles A. Gersbach , Rachael Potter
{"title":"基于 AAV 的 CRISPR-Cas9 基因组编辑:挑战与工程机遇","authors":"Ami M. Kabadi ,&nbsp;Maria Katherine Mejia-Guerra ,&nbsp;John D. Graef ,&nbsp;Sohrab Z. Khan ,&nbsp;Eric M. Walton ,&nbsp;Xinzhu Wang ,&nbsp;Charles A. Gersbach ,&nbsp;Rachael Potter","doi":"10.1016/j.cobme.2023.100517","DOIUrl":null,"url":null,"abstract":"<div><p>Recent innovations in the field of gene therapy have paved the way for advances towards developing genome editing medicines. Despite these steps forward, challenges with viral delivery of genome editing tools persist. Efforts currently underway include developing next-generation genome editors, overcoming adeno-associated virus (AAV) packaging restrictions, improving AAV genome integrity, engineering novel AAV capsids, and minimizing the immune response. This review discusses current challenges in delivering CRISPR-Cas nuclease-based genome editing therapies using AAV and highlights emerging methods to overcome these obstacles. This includes developing smaller payloads and regulatory elements, advancing novel sequencing methods for vector characterization, engineering capsids with enhanced potency, tissue-selectivity, and ability to evade pre-existing antibodies, controlling transgene expression, and minimizing the immune response to Cas proteins.</p></div>","PeriodicalId":36748,"journal":{"name":"Current Opinion in Biomedical Engineering","volume":"29 ","pages":"Article 100517"},"PeriodicalIF":4.7000,"publicationDate":"2023-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2468451123000739/pdfft?md5=23fd7e302b12d0dee1de084f88f1a6ed&pid=1-s2.0-S2468451123000739-main.pdf","citationCount":"0","resultStr":"{\"title\":\"AAV-based CRISPR-Cas9 genome editing: Challenges and engineering opportunities\",\"authors\":\"Ami M. Kabadi ,&nbsp;Maria Katherine Mejia-Guerra ,&nbsp;John D. Graef ,&nbsp;Sohrab Z. Khan ,&nbsp;Eric M. Walton ,&nbsp;Xinzhu Wang ,&nbsp;Charles A. Gersbach ,&nbsp;Rachael Potter\",\"doi\":\"10.1016/j.cobme.2023.100517\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>Recent innovations in the field of gene therapy have paved the way for advances towards developing genome editing medicines. Despite these steps forward, challenges with viral delivery of genome editing tools persist. Efforts currently underway include developing next-generation genome editors, overcoming adeno-associated virus (AAV) packaging restrictions, improving AAV genome integrity, engineering novel AAV capsids, and minimizing the immune response. This review discusses current challenges in delivering CRISPR-Cas nuclease-based genome editing therapies using AAV and highlights emerging methods to overcome these obstacles. This includes developing smaller payloads and regulatory elements, advancing novel sequencing methods for vector characterization, engineering capsids with enhanced potency, tissue-selectivity, and ability to evade pre-existing antibodies, controlling transgene expression, and minimizing the immune response to Cas proteins.</p></div>\",\"PeriodicalId\":36748,\"journal\":{\"name\":\"Current Opinion in Biomedical Engineering\",\"volume\":\"29 \",\"pages\":\"Article 100517\"},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2023-12-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2468451123000739/pdfft?md5=23fd7e302b12d0dee1de084f88f1a6ed&pid=1-s2.0-S2468451123000739-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Opinion in Biomedical Engineering\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2468451123000739\",\"RegionNum\":3,\"RegionCategory\":\"工程技术\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ENGINEERING, BIOMEDICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Opinion in Biomedical Engineering","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2468451123000739","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

摘要

基因治疗领域的最新创新为开发基因组编辑药物铺平了道路。尽管取得了这些进展,但基因组编辑工具的病毒传递仍面临挑战。目前正在进行的努力包括开发下一代基因组编辑器、克服腺相关病毒(AAV)包装限制、提高 AAV 基因组完整性、设计新型 AAV 病毒盖以及最大限度地减少免疫反应。本综述讨论了目前使用 AAV 提供基于 CRISPR-Cas 核酸酶的基因组编辑疗法所面临的挑战,并重点介绍了克服这些障碍的新方法。这包括开发更小的有效载荷和调控元件,推进用于载体特征描述的新型测序方法,设计具有更强效力、组织选择性和规避已有抗体能力的噬菌体,控制转基因表达,以及最大限度地减少对 Cas 蛋白的免疫反应。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
AAV-based CRISPR-Cas9 genome editing: Challenges and engineering opportunities

Recent innovations in the field of gene therapy have paved the way for advances towards developing genome editing medicines. Despite these steps forward, challenges with viral delivery of genome editing tools persist. Efforts currently underway include developing next-generation genome editors, overcoming adeno-associated virus (AAV) packaging restrictions, improving AAV genome integrity, engineering novel AAV capsids, and minimizing the immune response. This review discusses current challenges in delivering CRISPR-Cas nuclease-based genome editing therapies using AAV and highlights emerging methods to overcome these obstacles. This includes developing smaller payloads and regulatory elements, advancing novel sequencing methods for vector characterization, engineering capsids with enhanced potency, tissue-selectivity, and ability to evade pre-existing antibodies, controlling transgene expression, and minimizing the immune response to Cas proteins.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Current Opinion in Biomedical Engineering
Current Opinion in Biomedical Engineering Medicine-Medicine (miscellaneous)
CiteScore
8.60
自引率
2.60%
发文量
59
期刊最新文献
Rehabilitation of motor and sensory function using spinal cord stimulation: Recent advances Bioresorbable neural interfaces for bioelectronic medicine Neuromodulation for the treatment of sexual dysfunction: An opportunity for the field Enhancing resilience against adversarial attacks in medical imaging using advanced feature transformation training The prospect of electroceutical intervention and its implementation toward intractable neuromuscular diseases
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1